Selected EMA news, May 2025

New information on approved medicines

  • Adcetris (brentuximab vedotin) – new indication
    Treatment of lymphomas (cancers of lymphocytes, white blood cells that are part of the immune system)
  • Calquence (acalabrutinib) – new indication
    Treatment of chronic lymphocytic leukemia, a blood cancer affecting B cells (a type of white blood cell)
  • Jivi (damoctocog alfa pegol) – extension of indication
    Treatment and prevention of bleeding in patients with haemophilia A (an inherited bleeding disorder)

Supply shortages

  • NovoSeven (eptacog alfa (activated))
    Treatment of bleeding episodes and prevention of bleeding after surgical procedures
Share